IRCT2016111030821N1
Completed
Phase 4
Evaluation the effect of oral N-acetylcysteine on quantitative serum high sensitivity CRP and hemoglobin in end stage renal disease patients under hemodialysis
Vice Chancellor for research of Ardabil University of Medical Sciences0 sites40 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- End stage renal disease.
- Sponsor
- Vice Chancellor for research of Ardabil University of Medical Sciences
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •patients with positive CRP who were dialyzed at least three times per week for three months
- •Exclusion criteria: Patients with chronic inflammatory diseases such as rheumatoid arthritis and lupus, patients who take HRT drugs during menopause ,patients with malignant blood diseases such as myelodysplastic syndrome, lymphoma, leukemia, bone marrow aplasia and patients with HIV
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
evaluation of N-acetylcysteine on nitrosative stress in Rheumatoid arthritis patientsIRCT2017073022965N12Vice Chancellor for research of Hamadan University of Medical Sciences52
Completed
Not Applicable
Effect of N-acetylcysteine drug and oral contraceptive pill on chronic pelvic pain and endometriomaendometrioma.Endometriosis of ovaryN80.1IRCT20090526001952N11Tehran University of Medical Sciences112
Completed
Phase 3
Effects of N-acetylcysteine administration in treatment of women with gestational diabetes mellitusGestational diabetes mellitus.Unspecified diabetes mellitus in pregnancy, childbirth and the puerperiumO24.9IRCT20170513033941N71Kashan University of Medical Sciences76
Not yet recruiting
Phase 3
The effect of N-Acetylcysteine on COVID-19IRCT20200509047364N3Bandare-abbas University of Medical Sciences40
Recruiting
Phase 3
.Effect of N-acetylcysteeine on non-alcoholic fatty liver diseaseIRCT20201220049772N1Kashan University of Medical Sciences74